Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | JANUX THERAPEUTICS INC JANX | FMR LLC | 4,671,213 10.117% | -934,647![]() (-16.67%) | Filing History |
| 2024-02-01 4:15 pm Purchase | 2023-12-31 | 13G | JANUX THERAPEUTICS INC JANX | Bregua Corp | 3,830,257 8.300% | 81,007![]() (+2.16%) | Filing History |
| 2023-11-15 6:22 pm Purchase | 2023-11-13 | 13D | JANUX THERAPEUTICS INC JANX | Avalon Ventures XI L.P. | 9,766,354 21.200% | 869,645![]() (+9.77%) | Filing History |
| 2023-07-10 4:01 pm Purchase | 2023-06-29 | 13G | JANUX THERAPEUTICS INC JANX | Citadel Advisors LLC | 2,126,135 5.100% | 2,126,135![]() (New Position) | Filing History |
| 2023-05-30 4:45 pm Purchase | 2023-05-17 | 13G | JANUX THERAPEUTICS INC JANX | BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% | 4,106,945![]() (New Position) | Filing History |
| 2023-02-10 4:32 pm Purchase | 2022-12-31 | 13G | JANUX THERAPEUTICS INC JANX | Campbell David Alan | 2,379,935 5.400% | 103,323![]() (+4.54%) | Filing History |
| 2023-02-09 11:40 am Sale | 2022-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 1,837,791 4.400% | -563,102![]() (-23.45%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | JANUX THERAPEUTICS INC JANX | FMR LLC | 5,605,860 13.455% | 614,458![]() (+12.31%) | Filing History |
| 2023-01-20 5:32 pm Purchase | 2023-01-10 | 13G | JANUX THERAPEUTICS INC JANX | EcoR1 Capital, LLC | 3,255,270 7.800% | 3,255,270![]() (New Position) | Filing History |
| 2022-02-11 6:30 pm Purchase | 2021-12-31 | 13G | JANUX THERAPEUTICS INC JANX | JANUS HENDERSON GROUP Ltd. JHG | 2,400,893 5.800% | 2,400,893![]() (New Position) | Filing History |
| 2022-02-11 4:01 pm Purchase | 2021-12-31 | 13G | JANUX THERAPEUTICS INC JANX | Campbell David Alan | 2,276,612 5.500% | 2,276,612![]() (New Position) | Filing History |
| 2022-01-10 1:26 pm Purchase | 2022-01-07 | 13G | JANUX THERAPEUTICS INC JANX | FMR LLC | 4,991,402 11.995% | 4,991,402![]() (New Position) | Filing History |
| 2021-12-17 5:08 pm Sale | 2021-12-16 | 13D | JANUX THERAPEUTICS INC JANX | ORBIMED ADVISORS LLC | 2,649,464 6.400% | -393,300![]() (-12.93%) | Filing History |

